U 3774 U 3774 Pill - blue oval
Generic Name: estropipate
Pill with imprint U 3774 U 3774 is Blue, Oval and has been identified as Ogen 2.5 3 mg. It is supplied by Pharmacia Corp.
Ogen 2.5 is used in the treatment of Atrophic Vaginitis; Hypoestrogenism; Oophorectomy; Osteoporosis; Postmenopausal Symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Ogen 2.5 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for U 3774 U 3774


Ogen 2.5
- Generic Name
- estropipate
- Imprint
- U 3774 U 3774
- Strength
- 3 mg
- Color
- Blue
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Estrogens
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacia Corp
- National Drug Code (NDC)
- 00009-3774 (Discontinued)
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Evenity
Evenity (romosozumab) injection is used to treat osteoporosis in postmenopausal women to reduce the ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Boniva
Boniva (ibandronate) is used to treat or prevent osteoporosis in women after menopause. Includes ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
More about Ogen 2.5 (estropipate)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
Patient resources
Other brands
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.